Seelos Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
300 Park Avenue, 2 Nd Floor, New York, NY
State of incorporation
Nevada
Fiscal year end
December 31
Data updated at
9/4/2024, 01:27 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Feb 6, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G Report Jul 8, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 10, 2022
SC 13G Report Feb 4, 2022
SC 13G Report SCHEDULE 13G Feb 10, 2021
SC 13G/A Report SC 13G/A Jan 15, 2021
SC 13G/A Report Jan 11, 2021
SC 13G/A Report Feb 14, 2020
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 14, 2020
SC 13G/A Report SC 13G/A Feb 12, 2020
SC 13G/A Report SC 13G/A Feb 10, 2020
SC 13G Report Jan 16, 2020
SC 13G Report SC 13G Apr 15, 2019
SC 13G Report SC 13G Mar 11, 2019
SC 13G/A Report Feb 14, 2019
SC 13G Report REPORT OF ACQUISITION OF BENEFICIAL OWNERSHIP Feb 8, 2019
SC 13G/A Report SABBY 13G-A APRI 1.04.19 Jan 4, 2019
SC 13G Report SCHEDULE 13G Apr 9, 2018
SC 13G Report SABBY 13G APRI 3.29.18 Mar 29, 2018
SC 13G/A Report Feb 14, 2018
SC 13G/A Report Feb 14, 2018
SC 13G Report Sep 20, 2017
SC 13G Report Jun 16, 2017
SC 13G Report SCHEDULE 13G May 2, 2017
SC 13G/A Report SC 13G/A Feb 14, 2017
SC 13G/A Report SC 13G/A Feb 10, 2017
SC 13G/A Report SC 13G AMENDMENT NO. 1 Feb 6, 2017
SC 13G Report SC 13G Oct 7, 2016
SC 13G Report SC 13G Oct 3, 2016
SC 13G/A Report SC 13G/A Feb 17, 2015
SC 13G/A Report SC 13G/A Feb 17, 2015
SC 13G Report SC 13G Jan 5, 2015
SC 13G Report SC 13G Nov 20, 2014
SC 13G/A Report Feb 14, 2011
SC 13G Report Apr 1, 2010